Blue Finessence
Blue Finessence
  • Home
  • About Us
  • Services
    • Our Services
    • Company Formation in Europe
  • News
    • Internal News
    • General news
  • Contact
  • Your cart is currently empty.

    Sub Total: $ 0,00 View cartCheckout

RFK Jr. Says Officials Exploring Feasibility Of Breaking Up MMR Vaccine

Home / Finance / RFK Jr. Says Officials Exploring Feasibility Of Breaking Up MMR Vaccine
RFK Jr. Says Officials Exploring Feasibility Of Breaking Up MMR Vaccine
  • October 30, 2025
  • test
  • 74 Views

RFK Jr. Says Officials Exploring Feasibility Of Breaking Up MMR Vaccine

RFK Jr. Says Officials Exploring Feasibility Of Breaking Up MMR Vaccine

Authored by Zachary Stieber via The Epoch Times,

Federal officials are looking at separating vaccines for the measles and several other diseases into individual shots, Health Secretary Robert F. Kennedy Jr. said on Oct. 29.

“We’re looking at the feasibility of that now,” Kennedy told reporters in Washington after being asked about breaking up the combination measles, mumps, rubella (MMR) vaccine.

Kennedy did not offer more details.

“Immunizations for measles, mumps, and rubella would be best administered as three separate vaccines,” a spokesperson for the Department of Health and Human Services (HHS) told The Epoch Times in an email. “Standalone vaccinations can potentially reduce the risk of side effects and can maximize parental choice in childhood immunizations.”

President Donald Trump in September called for people to take separate shots against measles, mumps, and rubella. No individual shots against those diseases are currently available in the United States, according to the Centers for Disease Control and Prevention, which is part of HHS.

After Trump on Oct. 6 again said on social media that the MMR vaccine should be given in separate shots, acting CDC Director and Deputy HHS Secretary Jim O'Neill boosted the post and urged vaccine manufacturers to act.

He said the new shots should be safe and monovalent, or targeting one virus.

Merck, one of the manufacturers, has said it opposes separating combination vaccines because people are more likely to complete vaccine series with combination shots.

GlaxoSmithKline, the other manufacturer of the MMR vaccine, has not responded to requests for comment.

That same day, O'Neill signed off on recommendations from the CDC’s vaccine advisory panel, including a recommendation that the CDC stop recommending another combination vaccine to younger children.

The CDC no longer advises that children under 4 receive the measles, mumps, rubella, varicella vaccine. Instead, it recommends only the MMR vaccine, as well as a separate shot for varicella, for that age group.

The panel issued its advice to the CDC after reviewing data that indicate younger children faced an elevated risk of febrile seizures following receipt of the four-antigen vaccine.

The panel was slated to meet again in October, but that meeting has been postponed indefinitely.

The CDC says either the MMR vaccine or the other measles combination shot is good for children 4 and older.

The CDC’s vaccine schedule lists two doses of vaccines against measles, mumps, rubella, and varicella, commonly known as chickenpox. The first dose is recommended around 1 year of age. The second dose is advised for children 4 to 6.

Most states require measles and varicella vaccination for school, based on the schedule.

Nationwide, more than 90 percent of children have received an MMR vaccine, according to CDC data.

Kennedy has previously said that people should receive the MMR vaccine, describing it as “the most effective way to prevent the spread of measles.”

The number of measles cases in the United States over the summer reached the most in a year since 1992. Outbreaks are ongoing in South Carolina and several other states.

Tyler Durden
Thu, 10/30/2025 – 17:05

Tyler DurdenSource

Share:

Previus Post
Amazon Soars
Next Post
Harvard Scientist

Leave a comment

Cancel reply

Recent Posts

  • Independent assessment to support establishment of a Future Entity
  • Predisposizione, da parte dell’Agenzia delle entrate, delle bozze dei registri IVA, delle liquidazioni periodiche dell’IVA e della dichiarazione annuale dell’IVA di cui all’articolo 4 del decreto legislativo 5 agosto 2015, n. 127. Ulteriore estensione del periodo sperimentale stabilito con il provvedimento del Direttore dell’Agenzia delle entrate n. 183994 dell’8 luglio 2021 (provvedimento)
  • Istituzione delle causali contributo per il versamento, tramite modello F24, dei contributi all’INPS da destinare ad Enti Bilaterali (risoluzione n. 5)
  • Deadline for challenging your business rates valuation
  • Targeted financial support for aspiring social workers

Recent Comments

  1. validtheme on Digital Camera

Archives

  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Finance
  • internal news
  • Italy
  • Uncategorized
  • United Kingdom

Recent Posts

  • Independent assessment to support establishment of a Future Entity
    09 March, 2026Independent assessment to support
  • Predisposizione, da parte dell’Agenzia delle entrate, delle bozze dei registri IVA, delle liquidazioni periodiche dell’IVA e della dichiarazione annuale dell’IVA di cui all’articolo 4 del decreto legislativo 5 agosto 2015, n. 127. Ulteriore estensione del periodo sperimentale stabilito con il provvedimento del Direttore dell’Agenzia delle entrate n. 183994 dell’8 luglio 2021 (provvedimento)
    09 March, 2026Predisposizione, da parte dell’Agenzia
  • 09 March, 2026Istituzione delle causali contributo
  • Deadline for challenging your business rates valuation
    09 March, 2026Deadline for challenging your

Tags

Blue%20Finessence

Excellence decisively nay man yet impression for contrasted remarkably. There spoke happy for you are out. Fertile how old address did showing.

Contact Info

  • Address:CEO Blue FinEssence Ltd Piccadilly Circus 126 London
  • Email:director@bluefinessence.com
  • Phone:004407784915057

Copyright 2024 Bluefinessence. All Rights Reserved by Bluefinessence

  • About Us
  • Our Services